Jeffrey L. Evelhoch

Affiliations: 
Wayne State University, Detroit, MI, United States 
Area:
Radiology, Radiation Physics, Medical Biophysics
Google:
"Jeffrey Evelhoch"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Keenan KE, Biller JR, Delfino JG, et al. (2019) Recommendations towards standards for quantitative MRI (qMRI) and outstanding needs. Journal of Magnetic Resonance Imaging : Jmri
Keenan KE, Biller JR, Boss MA, et al. (2019) Progress Towards Standards for Quantitative MRI (qMRI) and Outstanding Needs Journal of Magnetic Resonance Imaging. 49
Evelhoch JL. (2018) In vivo MR in the drug pipeline. Journal of Magnetic Resonance (San Diego, Calif. : 1997)
Keenan KE, Ainslie M, Barker AJ, et al. (2017) Quantitative magnetic resonance imaging phantoms: A review and the need for a system phantom. Magnetic Resonance in Medicine
Campbell BR, Gonzalez Trotter D, Hines CD, et al. (2016) In Vivo Imaging in Pharmaceutical Development and Its Impact on the 3Rs. Ilar Journal. 57: 212-220
Seah S, Asad AB, Baumgartner R, et al. (2014) Investigation of cross-species translatability of pharmacological MRI in awake nonhuman primate - a buprenorphine challenge study. Plos One. 9: e110432
Becerra L, Upadhyay J, Chang PC, et al. (2013) Parallel buprenorphine phMRI responses in conscious rodents and healthy human subjects. The Journal of Pharmacology and Experimental Therapeutics. 345: 41-51
Schmidt E, Blackman S, Iannone R, et al. (2013) Abstract P4-01-11: Limits of [18F]-FLT PET as a clinical biomarker of proliferation in breast cancer Cancer Research. 73
Rossin R, Kohno T, Hagooly A, et al. (2011) Characterization of 64Cu-DOTA-conatumumab: a PET tracer for in vivo imaging of death receptor 5. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 942-9
Herbst RS, Hong D, Chap L, et al. (2009) Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 3557-65
See more...